Braveheart Bio, Inc. (BRVE)
NASDAQ: BRVE · Real-Time Price · USD
25.97
-0.18 (-0.69%)
At close: Aug 13, 2026, 4:00 PM EDT
26.48
+0.51 (1.96%)
After-hours: Aug 13, 2026, 7:58 PM EDT

Braveheart Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025
Period Ending
Aug '26 Dec '25
1,666-
Market Cap Growth
--
Enterprise Value
1,587-
Net Debt / Equity Ratio
-1.12-1.06
Quick Ratio
8.0617.01
Current Ratio
8.1117.03
Return on Capital Employed (ROCE)
-27.10%-5.40%
SEC Filings: 10-K · 10-Q